ATE219514T1 - Microsomales triglyceridtransferprotein - Google Patents

Microsomales triglyceridtransferprotein

Info

Publication number
ATE219514T1
ATE219514T1 AT93103697T AT93103697T ATE219514T1 AT E219514 T1 ATE219514 T1 AT E219514T1 AT 93103697 T AT93103697 T AT 93103697T AT 93103697 T AT93103697 T AT 93103697T AT E219514 T1 ATE219514 T1 AT E219514T1
Authority
AT
Austria
Prior art keywords
transfer protein
microsomal triglyceride
triglyceride transfer
methods
activity
Prior art date
Application number
AT93103697T
Other languages
English (en)
Inventor
Ii John R Wetterau
Daru Young Sharp
Richard E Gregg
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25300790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE219514(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of ATE219514T1 publication Critical patent/ATE219514T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
AT93103697T 1992-03-06 1993-03-08 Microsomales triglyceridtransferprotein ATE219514T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84750392A 1992-03-06 1992-03-06

Publications (1)

Publication Number Publication Date
ATE219514T1 true ATE219514T1 (de) 2002-07-15

Family

ID=25300790

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93103697T ATE219514T1 (de) 1992-03-06 1993-03-08 Microsomales triglyceridtransferprotein

Country Status (12)

Country Link
EP (1) EP0584446B2 (de)
JP (1) JP4298801B2 (de)
AT (1) ATE219514T1 (de)
AU (1) AU670930B2 (de)
CA (1) CA2091102C (de)
DE (1) DE69332041T3 (de)
DK (1) DK0584446T4 (de)
ES (1) ES2178640T5 (de)
HU (1) HU218419B (de)
MX (1) MX9301269A (de)
PT (1) PT584446E (de)
ZA (1) ZA931601B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595872A (en) * 1992-03-06 1997-01-21 Bristol-Myers Squibb Company Nucleic acids encoding microsomal trigyceride transfer protein
US5739135A (en) * 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
ZA961340B (en) 1995-02-21 1997-09-11 Bristol Myers Squibb Co Inhibitors of microsomal triglyceride transfer protein and method.
KR20000065152A (ko) * 1996-04-30 2000-11-06 디. 제이. 우드, 스피겔 알렌 제이 4'-트리플루오로메틸비페닐-2-카복실산2-(2에이치-[1,2,4]트리아졸-3-일메틸)-1,2,3,4-테트라히드로-이소퀴놀린-6-일-아미드를제조하기위한방법및이의중간체
US5885983A (en) * 1996-05-10 1999-03-23 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5827875A (en) * 1996-05-10 1998-10-27 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5883109A (en) * 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
CA2261162A1 (en) * 1996-07-24 1998-01-29 Bristol-Myers Squibb Company Method for treating tumors having high ldl requirements employing mtp inhibitors
US5760246A (en) 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
WO1998031366A1 (en) * 1997-01-17 1998-07-23 Bristol-Myers Squibb Company Method for treating atherosclerosis with an mpt inhibitor and cholesterol lowering drugs
EP1024804A4 (de) * 1997-05-01 2001-03-21 Bristol Myers Squibb Co Mtp-inhibitoren und fettlösliche vitamin-therapeutika zur verringerung des serum lipids
US5968950A (en) * 1997-06-23 1999-10-19 Pfizer Inc Apo B-secretion/MTP inhibitor hydrochloride salt
JP2959765B2 (ja) 1997-12-12 1999-10-06 日本たばこ産業株式会社 ３−ピペリジル−４−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
CA2324800A1 (en) * 1999-11-10 2001-05-10 Mary Anne Hickman Use of apo b secretion/mtp inhibitors
AU2953201A (en) * 2000-01-20 2001-07-31 Genome Therapeutics Corporation Rapid determination of gene structure using cdna sequence
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
JO2390B1 (en) 2001-04-06 2007-06-17 شركة جانسين فارماسوتيكا ان. في Diphenylcarboxamides act as lipid-lowering agents
SK287806B6 (sk) 2001-06-28 2011-10-04 Pfizer Products Inc. Triamid-substituované indoly, benzofurány a benzotiofény ako inhibítory mikrozómového proteínu prenášajúceho triglyceridu (MTP) a/alebo sekrécie apolipoproteínu B (Apo B)
WO2005043110A2 (en) * 2003-06-27 2005-05-12 The Research Foundation Of State University Of New York Fluorescence assay for mtp activity
WO2005080373A1 (en) 2004-02-04 2005-09-01 Pfizer Products Inc. Substituted quinoline compounds
WO2005087234A1 (en) 2004-03-05 2005-09-22 The Trustees Of The University Of Pennsylvania Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291205B1 (en) * 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae

Also Published As

Publication number Publication date
EP0584446B1 (de) 2002-06-19
HUT67962A (en) 1995-05-29
DE69332041T3 (de) 2011-05-05
HU9300627D0 (en) 1993-05-28
EP0584446A3 (de) 1995-04-26
HU218419B (hu) 2000-08-28
AU3406493A (en) 1993-09-09
DE69332041T2 (de) 2004-04-29
JP4298801B2 (ja) 2009-07-22
ES2178640T3 (es) 2003-01-01
DK0584446T3 (da) 2002-10-14
CA2091102A1 (en) 1993-09-07
EP0584446A2 (de) 1994-03-02
ES2178640T5 (es) 2010-06-01
DK0584446T4 (da) 2010-05-17
CA2091102C (en) 2009-05-26
AU670930B2 (en) 1996-08-08
DE69332041D1 (de) 2002-07-25
PT584446E (pt) 2002-09-30
JPH0638761A (ja) 1994-02-15
EP0584446B2 (de) 2010-03-10
ZA931601B (en) 1993-10-05
MX9301269A (es) 1993-09-01

Similar Documents

Publication Publication Date Title
ATE219514T1 (de) Microsomales triglyceridtransferprotein
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
NO176921C (no) Genteknologisk fremgangsmåte for fremstilling av et tPA-lignende protein, samt vertscelle som er i stand til å uttrykke et slikt protein
DK0920498T3 (da) Hamster EF-1alfa transskriptionelt, regulatorisk DNA
NO931889L (no) Protease og beslektede DNA-forbindelser
DE69837104D1 (de) An g-protein gekoppelte rezeptoren und deren verwendungen
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DK127786A (da) Fremgangsmaade til fremstilling af tgf-beta, dna og mrna, som koder for tgf-beta, samt replicerbare vektorer omfattende dna'en og vaertsceller indeholdende vektorerne
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
NO179412C (no) Hybrid DNA-molekyl som koder for fibronektinbindende protein, mikroorganismer inneholdende slike DNA-molekyler samt fremgangsmåte ved fremstilling av slikt protein
DK453782A (da) Dna-sekvenser, rekombinant plasmid samt anvendelser deraf
DE69736840D1 (de) Synthese von nukleosiden und polynukleotiden
DE3688900D1 (de) Expression von protein c.
DE3751269D1 (de) Expression des biologisch aktiven Faktors XIII.
ATE487737T1 (de) 32 humane sekretierte proteine
FR2694571B1 (fr) Polypeptides possédant une activité nitrilase, séquence d'ADN codant pour lesdits polypeptides, cassettes d'expression et micro-organismes hôtes permettant leur obtention.
DE69033756T2 (de) Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen
ATE61631T1 (de) Gen fuer ein protein mit insektizider wirkung.
KR930013111A (ko) 바실러스의 파라-니트로벤질 에스테라제를 암호화하는 재조합 dna 화합물 및 발현벡터
ATE344802T1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
IT8521507A0 (it) Vettore di clonaggio, molecole di dna ricombinante, ceppi di bacillus subtilis trasformati con dette molecole e metodi per l'espressione di geni eterologhi e produzione e secrezione di proteine codificate da detti geni.
ATE327334T1 (de) Atp- und nukleinsäure-bindendes protein mit helikase- und atpase eigenschaften
ATE107694T1 (de) Für a.nidulans-isopenicillin-n-synthetase codierende dns, deren verwendung und dafür codierende vektoren.
BR9810643A (pt) Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification

Ref document number: 0584446

Country of ref document: EP